Environmental factors as regulators and effecters of multistep carcinogenesis

Carcinogenesis

Volumn 20, Issue 4, 1999, Pages 519-527

  Minamoto, Toshinari ^b   Mai, Masayoshi ^b   Ronai, Ze'ev ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CHEMICAL MUTAGEN; CIGARETTE SMOKE; ENVIRONMENTAL MUTAGEN; HETEROCYCLIC AMINE; MUTAGENIC AGENT; ONCOPROTEIN; REGULATOR PROTEIN;

BACTERIAL INFECTION; CANCER RISK; CARCINOGENESIS; DNA METHYLATION; GERM LINE; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HUMAN; MUTAGENESIS; NUTRIENT; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; RNA TRANSLATION; SOMATIC MUTATION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION; VIRUS INFECTION; WART VIRUS;

EID: 0032991767     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.4.519     Document Type: Review

References (157)

1. Coleman, M.P., Esteve, J., Damiecki, P., Arslan, A. and Renard, H. (1993) Trends in cancer incidence and mortality. IARC Scientific Publications No. 121, IARC, Lyon, pp. 1-806.
2. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutation in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
3. Semenza, J.C. and Weasel, L.H. (1997) Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environ. Health Perspect., 105, 155-163.
4. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) P53 mutations in human cancers. Science, 253, 49-53.
5. Brash, D.E. (1997) Sunlight and the onset of skin cancer. Trends Genet., 13, 410-414.
6. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A. Wang, N.J. and Harris, C.C. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature, 350, 427-431.
7. 1. Proc. Natl Acad. Sci. USA, 80, 2695-2698.
8. Spruck, C. H., Rideout, W.M., Olumi, A.F. et al. (1993) Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res., 53, 1162-1166.
9. Denissenko, M.F., Pao, A., Tang, M. and Pfeifer, G.P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science, 274, 430-432.
10. Hollstein, M., Marion, M J., Lehman, T., Welsh, J., Harris, C.C., Martel-Planche, G., Kusters, I. and Montesano, R. (1994) P53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis, 15, 1-3.
11. IARC (1997) Cancer Incidence in Five Continents. IARC Scientific Publications No. 6, IARC, Lyon.
12. Stemermann, G.N. (1991) The pathology of breast cancer in Japanese women compared to other ethnic groups. Breast Cancer Res. Treat., 18, S67-S72.
13. Kakizoe, T. (1997) Cancer Statistics in Japan. FPCR publication. Tokyo, Japan, pp. 10-18.
14. Hartman, A., Blaszyk, H., Kovach, J.S. and Sommer, S.S. (1997) Epidemiology of p53 gene mutations in human breast cancer. Trends Genet., 13, 27.
15. Watanbe, M., Fukutome, K., Shiraishi, T., Murata, M., Kawamura, J., Shimazaki, J., Kotake, T. and Yatani, R. (1997) Differences in the p53 gene mutational spectra of prostate cancers between Japan and Western countries. Carcinogenesis, 18, 1355-1358.
16. Urban, T., Ricci, S., Lacave, R., Antoine, M., Kambouchner, M., Capron, F. and Bernaudin, J.F. (1996) Codon 12 Ki-ras mutation in non-small-cell lung cancer: comparative evaluation in tumoral and non-tumoral lung. Br. J. Cancer, 74, 1051-1055.
17. Ronai, Z., Yabubovskaya, M.S., Zhang, E. and Belitsky, G.A. (1996) K-ras mutation in sputum of patients with or without lung cancer. J. Cell. Biochem., 25 (suppl.), 172-176.
18. DeVivo, I., Marion, M.J., Smith, S.J., Carney, W.P. and Brandt-Rauf, P.W. (1994) Mutant c-Ki-ras p21 protein in chemical carcinogenesis in humans exposed to vinyl chloride. Cancer Causes Control, 5, 273-278.
19. Palmer, H.J. and Paulson, K.E. (1997) Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr. Rev., 55, 353-361.
20. Suzuki, Y.S., Forman, J.J. and Sevanian, A. (1997) Oxidants as stimulators of signal transduction. Free Rad. Biol. Med., 22, 269-285.
21. Sen, C.K. and Packer, L. (1996) Antioxidant and redox regulation of gene transcription. FASEB J., 10, 709-720.
22. Rosette, C. and Karin, M. (1996) UV and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science, 274, 1194-1197.
23. De-Metys, P., Urso, B., Christoffersen, C.T. and Shymko, R.M. (1995) Mechanism of insulin and IGF-I receptor activation and signal transduction specificity. Receptor dimer cross-linking, bell-shaped curves and sustained versus transient signaling. Ann. NY Acad. Sci., 766, 388-401.
24. Ginn-Pease, M.E. and Whisler, R.L. (1998) Redox signals and NF-kappaB activation in T cells. Free Radic Biol. Med., 25, 346-361.
25. Legrand-Poels, S., Zeecchinon, L., Piret, B., Schoonbroodt, S. and Piette, J. (1997) Involvement of different transduction pathway in NF-kappa B activation by several inducers. Free Radic Res., 27, 301-309.
26. Gotoh, Y. and Cooper, J.A. (1998) Reactive oxygen species-and dimerization-induced activation of apoptosis signal-reducing kinase 1 in tumor necrosis factor-alpha signal transduction. J. Biol. Chem., 273, 17477-17482.
27. Goldman, R., Ferber, E. and Zor, U. (1997) Involvement of reactive oxygen species in phospholipase A2 activation: inhibition of protein tyrosine phosphatases and activation of protein kinase. Adv. Exp. Med. Biol., 400A, 25-30.
28. Kanterewicz, B.I., Knapp, L.T. and Klann, E. (1998) Stimulation of p42 and p44 mitogen-activated protein kinases by reactive oxygen species and nitric oxide in hippocampus. J. Neurochem., 70, 1009-1016.
29. 2+]. J. Biol. Chem., 272, 29372-29379.
30. Tommasi, S., Denissenki, M.F. and Pfeifer, G.P. (1997) Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. Cancer Res., 57, 4727-4730.
31. Bowden, T.G., Finch, J., Domann, F. and Krieg, P. (1995). Molecular mechanisms involved in skin tumor initiation promotion and progression. In Mukhtar, H. (ed.) Skin Cancer Mechanisms and Human Relevance. CRC Press, Boca Raton, FL, pp. 99-112.
32. Griffiths, H.R., Mistry, P., Herbert, K.E. and Lunec, J. (1998) Molecular and cellular effects of ultraviolet light-induced genotoxicity. Crit. Rev. Clin. Lab. Sci., 35, 189-237.
33. Bender, K., Blattner, C., Knebel, A., Iordanov, M., Herrlich, P. and Rahmsdorf, H.J. (1997) UV-induced signal transduction. J. Photochem. Photobiol., 27, 1-17.
34. Zanke, B.W., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L.A., Zon, L., Kyriakis, J., Liu, F.F. and Woodgett, J.R. (1996) The stress-activated protein kinase pathway mediates cell death following injury induced by cisplatinum. UV irradiation or heat. Curr. Biol., 6, 606-613.
35. 2-terminal kinase activation mediated by UV-induced DNA lesions in melanoma and fibroblast cells. Cell Growth Differ., 6, 1437-1446.
36. Berra, E., Municio, M.M., Sanz, L., Frutos, S., Diaz-Meco, M.T. and Moscat, J. (1997) Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade. Mol. Cell Biol., 17, 4346-4354.
37. Assefa, Z., Garmyn, M., Bouillon, R., Merlevede, W., Vandenheede, J.R. and Agostinis, P. (1997) Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. J. Invest. Dermatol., 108, 886-891.
38. ras. J. Biol. Chem., 271, 23304-23309.
39. Iordanov, M., Bender, K., Ade, T., Schmid, W., Sachsenmaier, C., Engel, K., Gaestel, M. and Rahmsdorf, H.J. (1997) CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J., 16, 1009-1022.
40. Whitmarsh, A.J. and Davis, R.J. (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med., 74, 589-607.
41. Price, M.A., Cruzalegui, F.H. and Treisman, R. (1996) The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light. EMBO J., 15, 6552-6563.
42. Adler, V., Pincus, M.R., Minamoto, T. et al. (1997) Conformation-dependent phosphorylation of p53. Proc. Natl Acad. Sci. USA, 94, 1686-1691.
43. Piette, J., Piret, B., Bonizzi, G., Schoonbroodt, S., Merville, M.P., Legrand-Poels, S. and Bours, V. (1997) Multiple redox regulation in NF-kappaB transcription factor activation. Biol. Chem., 378, 1237-1245.
44. Adler, V., Polotskaya, A., Kim, J., Dolan, L., Davis, R., Pincus, M. and Ronai, Z. (1996) Dose rate and mode of exposure are key factors in JNK activation by UV irradiation. Carcinogenesis, 17, 2073-2076.
45. Adler, V., Yin, Z., Fuchs, S.Y. et al. (1999) Regulation of JNK signaling by GSTp. EMBO J., 18, 1321-1334.
46. Gupta, S.D., Campbell, B., Derijard, R. and Davis, J. (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science, 267, 389-393.
47. Ramaswamy, N.T. Ronai, Z. and Pelling, J.C. (1998) Rapid activation of JNK1 in UV-B epidermal keratinocytes. Oncogene, 16, 1501-1505.
48. Minden, A. and Karin, M. (1997) Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta, 1333, F85-F104.
49. Fuchs, S.Y., Adler, V., Pincus, M.R. and Ronai, Z. (1998) MEKK1/JNK stabilizes and activates p53. Proc. Natl Acad. Sci. USA, 95, 10541-10546.
50. Fuchs, S.Y., Dolan, L., Davis, R.J. and Ronai, Z. (1996) Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene, 13, 1531-1535.
51. 2-terminal kinases target the ubiquitination of their associated transcription factors. J. Biol. Chem., 272, 32163-32168.
52. Fuchs, S.Y., Fried, V.A. and Ronai, Z. (1998) Stress activated protein kinases regulate protein stability. Oncogene, 17, 1483-1490.
53. Chen, Y.R., Wang X., Templeton, D., Davis, R.J. and Tan, T.H. (1996) The role of c-jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem., 271, 31929-31936.
54. El-Bayoumy, K., Chung, F.L., Richie, J. Jr. Reddy, B.S., Cohen, L., Weisburger, J. and Wynder, E.L., (1997) Dietary control of cancer. Proc. Soc. Exp. Biol. Med., 216, 211-223.
55. American Institute for Cancer Research. (1997) Diet and cancer processes. In Cannon, G. (ed.) Food Nutrition and the Prevention of Cancer: a Global Perspective. BANTA Book Group, Menasha, pp. 428-500.
56. Poirier, L.A., Newberne, P.M. and Pariza, M.W. (1986) Essential Nutrients in Carcinogenesis. Plenum Press, New York.
57. Steinmetz, K.A. and Potter, J.D. (1991) Vegetables, fruit and cancer. II Mechanisms. Cancer Causes Control, 2, 427-142.
58. Birt, D.F. Kris, E.S., Choe, M. and Pelling, J.C. (1992) Dietary energy and fat effects on tumor promotion. Cancer Res., 52, 2035s-2039s.
59. Nagao, M., Ushijima, T. Toyota, M., Inoue, R. and Sugimura, T. (1997) Genetic changes induced by heterocyclic amines. Mutat. Res., 376, 161-167.
60. Miller, J.A. and Miller, E.C. (1953) The carcinogenic aminoazo dyes. Adv. Cancer Res., 1, 339-396.
61. Ames, B.N. (1983) Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science, 221, 1256-1264.
62. Fujiki, H., Suganuma, M., Suguri, H., Yoshizawa, S., Hirota, M., Takagi, K. and Sugimura, T. (1989) Diversity in the chemical nature and mechanism of response to tumor promoters. Skin Carcinogenesis: Mechanism and Human Relevance. CRC Press, Boca Raton, FL, pp. 281-291.
63. Pariza, M.W. (1987) Fat, calories and mammary carcinogenesis: net energy effects. Am J. Clin. Nutr., 45, 261-263.
64. Warner, B.B., Stuart, L., Gebb, S. and Wispe, J.R. (1996) Redox regulation of manganese superoxide dismutase. Am. J. Physiol., 271, L150-L158.
65. 2-terminal kinases. J. Biol. Chem., 271, 15703-15707.
66. Chen, Q., Olashaw, N. and Wu, J. (1995) Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase activation pathway. J. Biol. Chem., 270, 28499-28502.
67. 2. Am. J. Physiol., 273, L1029-L1035.
68. Wilhelm, D., Bender, K., Knebel, A. and Angel, P. (1997) The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transaction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol. Cell Biol., 17, 4792-4800.
69. Pinkus, R., Weiner, L.M. and Daniel, V. (1996) Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB and glutathione S-transferase gene expression. J. Biol. Chem., 271, 13422-13429.
70. American Institute for Cancer Research (1997) Diet and cancer process. In Cannon, G. (ed.) Food, Nutrition and the Prevention of Cancer: a Global Perspective. BANTA Book Group. Menasha, pp. 96-108.
71. Walter-Sack, I. and Klotz, U. (1996) Influence of diet and nutritional status on drug metabolism. Clin. Pharmacokinet., 31, 47-64.
72. Kuipers, E.J., Uyterlinde, A.M., Pena, A.S., Roosendaal, R., Pals, G., Nelis, G.F., Festen, H.P.M. and Meuwissen, S.G. (1995) Long-term effect of Helicobacter pylori gastritis. Lancet, 345, 1525-1528.
73. Marchetti, M., Arico, B., Burroni, D., Figura, N., Rappouli, R. and Ghiara, P. (1995) Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science, 267, 1655-1658.
74. Mannick, E., Bravo, L.E. and Zarama, G. (1996) Inducible nitric oxide synthase, nitrotyrosine and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res., 56, 3238-3243.
75. Schiffman, M.H. (1992) Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J. Natl Cancer Inst., 84, 394-398.
76. Cullen, A.P., Reid, R., Campion, M. and Lorincz, A.Z. (1991) Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol., 65, 606-612.
77. Werness, B.A., Levine, A.J. and Howley, P.M. (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76-79.
78. Dyson, N., Howley, P.M. Munger, K. and Harlow, E. (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 243, 934-937.
79. Crook, T. and Vousden, K.H. (1994) Interaction of HPV E6 with p53 and associated proteins. Biochem. Soc. Trans, 22, 52-55.
80. Hoppe-Seyler, F. and Butz, K. (1994) Cellular control of human papillomavirus oncogene transcription. Mol. Carcinogen., 10, 134-141.
81. Scheffner, M., Werness, B.A., Huibregste, J.M., Levine, A.J. and Howley, P.M. (1990) The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136.
82. Kobayashi, S., Hayashi, H., Itoh, Y., Asano, T. and Isono, K. (1994) Detection of minus-strand hepatitis C virus RNA in tumor tissues of hepatocellular carcinoma. Cancer, 73, 48-52.
83. Moriya, K., Fujie, H., Shintani, Y. et al. (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nature Med., 4, 1065-1067.
84. Sakamuro, D., Furukawa, T. and Takegami, T. (1995) Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J. Virol., 69, 3893-3896.
85. Saito, S., Kato, N., Hijikata, M., Gunji, T., Itahashi, M., Kondo, M. Tanaka, K. and Shimotohno, K. (1996) Comparison of hypervariable regions (HVR1 and HVR2) in positive-and negative-stranded hepatitis C virus RNA in cancerous and non-cancerous liver tissue, peripheral blood mononuclear cells and serum from a patient with hepatocellular carcinoma. Int. J. Cancer Res., 67, 199-203.
86. Okada, S., Ishii, H., Hose, H., Okusaka, T., Kyogoku, A., Yoshimori, M. and Wakabayashi, K. (1997) Evidence for increased somatic cell mutations in patients with hepatocellular carcinoma. Carcinogenesis, 18, 445-449.
87. Teramoto, T., Satonaka, K., Kitazawa, S., Fujimori, T. Hayashi, K. and Maeda, S. (1994) P53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res., 54, 231-235.
88. Robinson, W.S. (1994) Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annu. Rev. Med., 45, 297-323.
89. Cromlish, J.A. (1996) Hepatitis B virus-induced hepatocellular carcinoma: possible roles for HBx. Trends Microbiol., 4, 270-274.
90. Wu, J.Y., Zhou, Z.Y., Judd, A., Cartwright, C.A. and Robinson, W.S. (1990) The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase. Cell, 63, 687-695 [published erratum appears in Cell, 75, 826].
91. Dopheide, T.A. and Azad, A.A. (1996) The hepatitis B virus X protein is a potent AMP kinase. J. Gen. Virol., 77, 173-176.
92. Doria, M., Klein, N., Lucito, R. and Schneider, R.J. (1995) The hepatitis B virus HB X protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J., 14, 4747-4757.
93. Kim, C.M., Koike, K., Saito, I., Miyamura, T. and Jay, G. (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature, 351, 317-320.
94. Beroud, C. and Soussi, T. (1996) APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res., 24, 121-124.
95. Wantabe, M. Kakiuchi, H., Kato, H., Shiraishi, T. Yatani, R., Sugimura, T. and Nagao, M. (1996) APC gene mutations in human prostate cancer. Jpn J. Clin. Oncol., 26, 77-81.
96. Harris, C.C. (1996) p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment. Environ. Health Perspect., 104, 435-439.
97. Birch, J.M., Hartley, A.L., Tricker, K.J. et al. (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res., 54, 1298-1304.
98. Sidransky, D. (1996) Clinical implications of the p53 gene. Annu. Rev. Med., 47, 285-301.
99. Inoue, R., Fukutomi, T., Ushijima, T., Matsumoto, Y., Sugimura, T. and Nagao, M. (1995) Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res., 55, 3521-3524.
100. Gayther, S.A., Mangion, J., Russel, P., Seal, S., Barfoot, R., Ponder, B.A.J., Stratton, M.R. and Easton, D. (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nature, 15, 14-15.
101. Inoue, R., Ushijima, T., Fukutomi, T. et al. (1997) BRCA2 germline mutations in Japanese breast cancer families. Int. J. Cancer, 74, 199-204.
102. Couch, F.J., Farid, L.M., DeShano, M.L. et al. (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genet., 13, 123-125.
103. Bell, D.A., Thompson, C.L., Taylor, J., Miller, C.R., Perera, F., Hsieh, L.L. and Lucier, G.W. (1992) Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase μ. Environ. Health Perspect., 98, 113-117.
104. Nakajima, T., Elovaara, E., Anttila, S., Hirvonen, A., Camus, A.-A., Hayes, J.D., Ketterer, B. and Vainio, H. (1995) Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis, 16, 707-711.
105. Kato, S., Shields, P.G., Caporaso, N.E., Hoover, R.N., Trump, B.F., Sugimura, H., Weston, A. and Harris, C.C. (1992) Cytochrome P450IIE1 genetic polymorphisms, racial variation and lung cancer. Cancer Res., 52, 6712-6715.
106. Oyama, T., Kawamoto, T., Mizoue, T., Sugio, K., Kodama, Y., Mitsudomi, T. and Yasumoto, K. (1997) Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res., 17, 583-588.
107. Hayashi, S.I., Wantanbe, J., Nakachi, K. and Kawajiri, K. (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J. Biochem., 110, 407-411.
108. Bartsch, H. and Hietanen, E. (1996) The role of individual susceptibility in cancer burden related to environmental exposure. Environ. Health Perspect., 104, 569-577.
109. Xu, Y., Bradham, C., Brenner, D.A. and Czaja, M.J. (1997) Hydrogen peroxide-induced liver cell necrosis is dependent on AP-1 activation. Am. J. Physiol., 273, G795-G803.
110. Ozolins, T.R. and Hales, B.F. (1997) Oxidative stress regulates the expression and activity of transcription factor activator protein-1 in rat conceptus. J. Pharmacol. Exp. Ther., 280, 1085-1093.
111. 2-resistant fibroblasts. Free Radic. Biol. Med., 20, 735-741.
112. Jin, D.-Y., Chae, H.Z., Rhee, S.G. and Jeang, K.-T. (1997) Regulatory role for a novel human thioredoxin peroxidase in NF-KB activation. J. Biol. Chem., 272, 30952-30961.
113. Vanhaesebroeck, B., Leevers, S.J., Panayotou, G. and Waterfield, M.D. (1997) PI3K - a conservered family of signal transducers. Trends Biochem. Sci., 22, 267-272.
114. Gu, W. and Roeder, R.G. (1997) Activation of p53 sequence specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
115. Sakaguchi, K., Herrera, J.E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C.W. and Appella, E. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev., 12, 2831-2841.
116. Shi, C.Y. Chua, S.C. Lee, H.P. and Ong, C.N. (1994) Inhibition of aflatoxin B1-DNA binding and adduct formation by selenium in rats. Cancer Lett., 82, 203-208.
117. Chou, M.W., Pegram, R.A., Gao, P. and Allaben, W.T. (1992) Effects of caloric restriction on aflatoxin B1 metabolism and DNA modification in Fischer 344 rats. In Fishbein, L. (ed.) Biological Effects of Dietary Restriction. Springer-Verlag, Berlin, pp. 42-45.
118. Cheng, Z., Hu, J., King, J., Jay, G. and Campbell, T.C. (1998) Inhibition of hepatocellular carcinoma development in hepatitis B virus transfected mice by low dietary casein. Hepatology, 26, 1351-1354.
119. Pogribny, I.P., Basnakian, A.G., Miller, B.J., Lopatina, N.G., Poirier, L.A. and James, S.J. (1995) Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res., 55, 1894-1901.
120. Christman, J.K., Sheikhnejad, G., Dizik, M., Abileah, S. and Wainfan, E. (1993) Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis, 14, 551-557.
121. Smith, M.L., Yeleswarapu, L. Scalamogna, P., Locker, J. and Lombardi, B. (1993) p53 mutations in hepatocellular carcinomas induced by a choline-devoid diet in male Fischer 344 rats. Carcinogenesis, 14, 503-510.
122. Wainfan, E. and Poirier, L.A. (1992) Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res., 52, 2071s-2077s.
123. Glynn, S.A. and Albanes, D. (1994) Folate and cancer: a review of the literature. Nutr. Cancer, 22, 101-119.
124. Hass, B.S., Hart, R.W., Lu, M.H. and Lyn-Cook, B.D. (1993) Effects of caloric restriction in animals on cellular function, oncogene expression and DNA methylation in vitro. Mutat. Res., 295, 281-289.
125. Hursting, S.D., Perkins, S.N. and Phang, J.M. (1994) Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc. Natl Acad. Sci. USA, 91, 7036-7040.
126. Sawada, N., Poirier, L., Moran, S., Xu, Y.H. and Pitot, H.C. (1990) The effect of choline and methionine deficiencies on the number and volume percentage of altered hepatic foci in the presence or absence of diethylnitrosamine initiation in rat liver. Carcinogenesis, 11, 273-281.
127. Zeisel, S.H. (1992) Choline: an important nutrient in brain development, liver function and carcinogenesis. J Am. Coll. Nutr., 11, 473-181.
128. Hilakivi-Clarke, L., Stoica, A., Raygada, M. and Martin, M. (1998) Consumption of high fat diet alters estrogen receptor content, protein kinase C activity and mammary gland morphology in virgin and pregnant mice and female offspring. Cancer Res., 58, 654-660.
129. Bandyopadhyay, G.K., Imagawa, W., Wallace, D. and Nandi, S. (1987) Linoleate metabolites enhance the in vitro proliferative response of mouse mammary epithelial cells to epidermal growth factor. J. Biol. Chem., 262, 2750-2756.
130. Connolly, J.M. and Rose, D.P. (1992) Interactions between epithelial growth factor-mediated autocrine regulation and linoleic acid-stimulated growth of a human prostate cancer cell line. Prostate. 20, 151-158.
131. Sylvester, P.W., Birkenfeld, H.R. Hosick, H.L. and Briski, K.P. (1994) Fatty acid modulation of epidermal growth factor-induced mouse mammary epithelial cell proliferation in vitro. Exp. Cell Res., 214, 145-153.
132. Choe, M., Kris, E.S., Luthra, R., Copenhaver, J., Pelling, J.C., Donnelly, T.E. and Birt, D.F. (1992) Protein kinase C is activated and diacylglycerol is elevated in epidermal cells from Sencar mice fed high fat diets. J. Nutr., 122, 2322-2329.
133. Correa, P., Miller, M. and Mannick, E.E. (1997) Oxidative damage during the gastric precancerous process. In Tahara, E. (ed.) Molecular Pathology of Gastroenterological Cancer. Springer-Verlag, Tokyo, Japan, pp. 23-30.
134. Hague, A., Elder, D.J., Hicks, D.J. and Paraskeva, C. (1995) Apoptosis in colorectal tumor cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int. J. Cancer, 60, 400-406.
135. Heerdt, B.G., Houston, M.A. and Augenlicht, L.H. (1997) Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondial function. Cell Growth Differ., 8, 523-532.
136. Shao, Z.M., Dawson, M.I., Li, X.S., Rishi, A.K., Sheikh, M.S., Han, Q.X., Ordonez, J.V. Shroot, B. and Fontana, J.A. (1995) p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogens, 11, 493-504.
137. Adler, V., Pincus, M.R., Posner, S., Upadhyaya, P., El-Bayoumy, K. and Ronai, Z. (1996) Effects of chemopreventive selenium compounds on Jun N-kinase activities. Carcinogenesis, 17, 1849-1854.
138. Foiles, P.G., Fujiki, H., Suganuma, M., Okabe, S., Yatsunami, J., Miglietta, L.M., Upadhyaya, P., El-Bayoumy, K. and Ronai, Z. (1995) Inhibition of PKA by chemopreventive organoselenium compounds. Int. J. Oncol., 7, 685-690.
139. Fiala, E.S., Staretz, M.E., Pandya, G.A., El-Bayoumy, K. and Hamilton, S. (1998) Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis, 19, 597-604.
140. Tillotson, J.K., Upadhyaya, P. and Ronai, Z. (1994) Inhibition of thymidine kinase in cultured mammary tumor cells by the chemopreventive organoselenium compound. 1,4-phenylenebis (methylene)selenocyanate. Carcinogenesis, 15, 607-610.
141. Ronai, Z., Tillotson, J.K., Traganos, F., Darzynkicz, Z., Conway, C.C. Upadhyaya, P. and El-Bayoumy, K. (1995) Effects of organic and inorganic selenium compounds on rat mammary tumor cells. Int. J. Cancer, 63, 428-434.
142. Liang, Y.C., Lin-Shiau, S.Y. Chen, C.T. and Lin, J.F. (1997) Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J. Cell, Biochem., 67, 55-65.
143. Dong, Z., Ma, W., Huang, C. and Yang, C.S. (1997) Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. Cancer Res., 57, 4414-4419.
144. Kitano, K., Nam, K.Y., Kimura, S., Fujiki, H. and Imanishi, Y. (1997) Sealing effects of (-)-epigallocatechin gallate on protein kinase C and protein phosphatase 2A. Biophys Chem., 65, 157-164.
145. The EUROGAST Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet, 341, 1359-1362.
146. Wang, Z.Y., Huang, M.T., Lou, Y.R., Xie, J.G., Reuhl, K.R., Newmark, H.L., Ho, C.T., Yang, C.S. and Conney, A.H. (1994) Inhibitory effects of black tea, decaffeinated black tea and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-I mice. Cancer Res., 54, 3428-3435.
147. Benn, J., Su, F., Doria, M. and Schneider, R.J. (1996) Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-jun N-terminal mitogen-activated protein kinases. J. Virol., 70, 4978-4985.
148. Benn, J. and Schneider, R.J. (1994) Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad. Sci. USA, 91, 10350-10354.
149. Feitelson, M.A., Zhu, M., Duan, L.X. and London, W.T. (1993) Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with hepatocellular carcinoma. Oncogene, 8, 1109-1117.
150. Truant, R., Antunovic, J., Greenblatt, J., Prives, C. and Cromlish, J.A. (1995) Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J. Virol., 69, 1851-1859.
151. Benn, J. and Schneider, R.J. (1995) Hepatitis B virus HBx protein regulates cell cycle checkpoint control. Proc Natl Acad. Sci. USA, 92, 11215-11219.
152. Wang, X.W., Gibson, M.K., Vermeulen, W., Yeh, H., Forrester, K., Sturzbecher, H.W., Hoeijmakers, J.H. and Harris, C.C. (1995) Abrogation of p53-induced apoptosis by the hepatitis B virus x gene. Cancer Res., 55, 6012-6016.
153. Qadri, I., Conaway, J.W., Conaway, R.C., Schaack, J. and Siddiqui, A. (1996) Hepatitis B virus transactivator protein. HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Natl Acad. Sci. USA, 93, 10578-10583.
154. Yoo, Y.D., Ueda, H., Park, K., Flanders, K.C., Lee, Y.I., Jay, G. and Kim, S.J. (1996) Regulation of transforming growth factor-beta I expression by the hepatitis B virus (HBV) x transactivator. Role in HBV pathogenesis. J. Clin. Invest, 97, 388-395.
155. Kim, S.O., Park, J.G. and Lee, Y.I. (1996) Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus x gene product. Cancer Res., 56, 3831-3836.
156. Capovilla, A., Carmona, S. and Arbulhnot, P. (1997) Hepatitis B virus x-protein binds damaged DNA and sensitizes liver cells to ultraviolet irradiation. Biochem. Biophys. Res. Commun., 232, 255-260.
157. Jia, L., Wang, X.W. and Harris, C.C. (1999) Hepatitis virus x protein inhibits nucleotide excision repair. Int. J. Cancer, in press.